Spain· ES:10648023
TWYNSTA 80 mg/10 mg COMPRIMIDOS
A medicinal product containing telmisartán + amlodipino, registered in Spain by Boehringer Ingelheim International Gmbh.
Checked against AEMPS CIMA (Spain) on
Informational only — not a medical device.
The record
At a glance
AEMPS CIMA (Spain)- Active substance
- telmisartán + amlodipino
- Manufacturer
- Boehringer Ingelheim International Gmbh
- Country
- Spain (ES)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- AEMPS CIMA (Spain)
- Last checked
- September 12, 2026
Packs & prices · 1
1 priced- cima_codigo70057128EUR 12.68
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Telmisartán + amlodipino in 12 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaTAMLOSETKrka, d.d., Novo mesto, Novo mesto
- FinlandOnduarpBoehringer Ingelheim International GmbH
- PolandTelamZakłady Farmaceutyczne POLPHARMA S.A.
- United StatesTelmisartan and AmlodipineLupin Pharmaceuticals, Inc.
- FranceTELMISARTAN/AMLODIPINE ARROW 40 mg/10 mg, compriméARROW GENERIQUES
- SwitzerlandMicardis Amlo 40/5 mg, TablettenBoehringer Ingelheim (Schweiz) GmbH
- CanadaAPO-TELMISARTAN-AMLODIPINEAPOTEX INC
- IcelandTwynstaBoehringer Ingelheim International GmbH*
Authorised across Europe · EMA
The same active substance is authorised in 18 EEA countries. Names it is sold under:
- Austria · Telmisartan/Amlodipin Krka
- Bulgaria · Актелсар Дуо, Равентон
- Czechia · Tamloset, Telassmo
- Germany · Actelsar Duo, Telmisartan/Amlodipin 089pharm
- Estonia · Mixor, Teldipin
- France · Telmisartan/Amlodipine Arrow
- Greece · Cardynsta
- Hungary · Arettan, Cotanydon
- Iceland · Twynsta
- Liechtenstein · Twynsta
- Lithuania · Raventon
- Latvia · Mixor, Raventon
- Norway · Twynsta
- Poland · Telam, Teldipin
- Portugal · Amlodipina + Telmisartan Generis, Amlodipina + Telmisartan Krka
- Romania · Telassmo
- Slovenia · Telassmo
- Slovakia · Mixor, Teldipin
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of AEMPS CIMA (Spain). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/f0957ae8-d732-421b-8cf5-a31d3f6cf3f6 GET /v1/drugs/f0957ae8-d732-421b-8cf5-a31d3f6cf3f6?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cpresc": "Medicamento Sujeto A Prescripción Médica",
"estado": "{\"aut\":1290034800000}",
"nregistro": "10648023",
"substance": "telmisartán + amlodipino"
}See everything about telmisartán + amlodipino.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.